4.7 Review

Streamlining Ethical Review

期刊

ANNALS OF INTERNAL MEDICINE
卷 153, 期 10, 页码 655-657

出版社

AMER COLL PHYSICIANS
DOI: 10.7326/0003-4819-153-10-201011160-00008

关键词

-

资金

  1. Intramural NIH HHS [Z99 CL999999] Funding Source: Medline

向作者/读者索取更多资源

The review system for human subjects research in the United States has been widely criticized in recent years for requirements that delay research without improving human subject protections. Any major reformulation of regulations may take some time to implement. However, current regulations often allow for streamlined ethics review that does not jeopardize-and may improve-protections for research participants. The authors discuss under-utilized options, including research that need not be classified as human subjects research, categories of studies that can be exempt from ethical review, studies that need only undergo expedited review by 1 institutional review board (IRB) member, and simplifying reviews of multicenter research by using the IRB of 1 institution. The authors speculate on multiple reasons for the underuse of these mechanisms and exhort IRBs and researchers to take advantage of these important opportunities to improve the review process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据